Patents by Inventor Bhanvi MEHTA

Bhanvi MEHTA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa
    Patent number: 11844860
    Abstract: A pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa as active ingredients and one or more excipients. Once dispersed in an aqueous medium, melevodopa is completely dissolved, and carbidopa is present as nanoparticles.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: December 19, 2023
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Ricardo Inacio, Mark Saunders, Bhanvi Mehta, Kathrin Muehlhoelzl-Odoerfer, Isabel Sole Font, Grazia Caivano
  • A PHARMACEUTICAL FORMULATION FOR INTRADUODENAL ADMINISTRATION COMPRISING MELEVODOPA AND CARBIDOPA
    Publication number: 20210007984
    Abstract: A pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa as active ingredients and one or more excipients. Once dispersed in an aqueous medium, melevodopa is completely dissolved, and carbidopa is present as nanoparticles.
    Type: Application
    Filed: February 21, 2019
    Publication date: January 14, 2021
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Ricardo INACIO, Mark SAUNDERS, Bhanvi MEHTA, Kathrin MUEHLHOELZL-ODOERFER, Isabel Sole FONT, Grazia CAIVANO